Importance of microbial natural products and the need to revitalize their discovery
- PMID: 23990168
- DOI: 10.1007/s10295-013-1325-z
Importance of microbial natural products and the need to revitalize their discovery
Abstract
Microbes are the leading producers of useful natural products. Natural products from microbes and plants make excellent drugs. Significant portions of the microbial genomes are devoted to production of these useful secondary metabolites. A single microbe can make a number of secondary metabolites, as high as 50 compounds. The most useful products include antibiotics, anticancer agents, immunosuppressants, but products for many other applications, e.g., antivirals, anthelmintics, enzyme inhibitors, nutraceuticals, polymers, surfactants, bioherbicides, and vaccines have been commercialized. Unfortunately, due to the decrease in natural product discovery efforts, drug discovery has decreased in the past 20 years. The reasons include excessive costs for clinical trials, too short a window before the products become generics, difficulty in discovery of antibiotics against resistant organisms, and short treatment times by patients for products such as antibiotics. Despite these difficulties, technology to discover new drugs has advanced, e.g., combinatorial chemistry of natural product scaffolds, discoveries in biodiversity, genome mining, and systems biology. Of great help would be government extension of the time before products become generic.
Similar articles
-
Microbial genome mining for accelerated natural products discovery: is a renaissance in the making?J Ind Microbiol Biotechnol. 2014 Feb;41(2):175-84. doi: 10.1007/s10295-013-1389-9. Epub 2013 Dec 17. J Ind Microbiol Biotechnol. 2014. PMID: 24342967 Free PMC article. Review.
-
Natural product discovery: past, present, and future.J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):155-76. doi: 10.1007/s10295-015-1723-5. Epub 2016 Jan 6. J Ind Microbiol Biotechnol. 2016. PMID: 26739136 Review.
-
Artificial intelligence in microbial natural product drug discovery: current and emerging role.Nat Prod Rep. 2022 Dec 14;39(12):2215-2230. doi: 10.1039/d2np00035k. Nat Prod Rep. 2022. PMID: 36017693 Free PMC article. Review.
-
Antibiotic discovery through microbial interactions.Curr Opin Microbiol. 2019 Oct;51:64-71. doi: 10.1016/j.mib.2019.06.006. Epub 2019 Jul 22. Curr Opin Microbiol. 2019. PMID: 31344518 Review.
-
Marine Microbial Secondary Metabolites: Pathways, Evolution and Physiological Roles.Adv Microb Physiol. 2015;66:357-428. doi: 10.1016/bs.ampbs.2015.04.001. Epub 2015 May 30. Adv Microb Physiol. 2015. PMID: 26210108 Review.
Cited by
-
Ultraviolet (IUV) and mass spectrometry (IMS) imaging for the deconvolution of microbial interactions.BMC Syst Biol. 2018 Nov 20;12(Suppl 5):99. doi: 10.1186/s12918-018-0617-3. BMC Syst Biol. 2018. PMID: 30458793 Free PMC article.
-
Molecular Networking-Based Metabolome and Bioactivity Analyses of Marine-Adapted Fungi Co-cultivated With Phytopathogens.Front Microbiol. 2018 Sep 6;9:2072. doi: 10.3389/fmicb.2018.02072. eCollection 2018. Front Microbiol. 2018. PMID: 30237790 Free PMC article.
-
Bioactive Compounds Isolated from Marine-Derived Microbes in China: 2009-2018.Mar Drugs. 2019 Jun 6;17(6):339. doi: 10.3390/md17060339. Mar Drugs. 2019. PMID: 31174259 Free PMC article. Review.
-
Ultrastructural changes in methicillin-resistant Staphylococcus aureus (MRSA) induced by metabolites of thermophilous fungi Acrophialophora levis.PLoS One. 2021 Oct 14;16(10):e0258607. doi: 10.1371/journal.pone.0258607. eCollection 2021. PLoS One. 2021. PMID: 34648570 Free PMC article.
-
Fabclavine diversity in Xenorhabdus bacteria.Beilstein J Org Chem. 2020 May 7;16:956-965. doi: 10.3762/bjoc.16.84. eCollection 2020. Beilstein J Org Chem. 2020. PMID: 32461774 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous